Together with our partners, we leverage knowledge, experience and insight – enabling us to deploy appropriate financial products for the market, for our partners and ultimately for patients.
MedAccess is a wholly owned subsidiary of British International Investment and forms a key component of the UK development finance institution’s Catalyst Strategies.British International Investment
Our agreement with Gavi enables the global vaccine alliance to support continued production of antigen for the RTS,S malaria vaccine by GSK in advance of key policy and funding decisions.Gavi
We work with PATH on a volume guarantee for SD Biosensor’s G6PD testing devices and strips to help doctors administer the most effective treatment for P. vivax malaria to people with G6PD deficiency.PATH
Funding provided through UK aid improves access in lower -resource settings to products for infectious diseases such as HIV, TB and malaria by supporting us to enter into new partnerships.UK aid
Our partnership is increasing and accelerating access to vital COVID-19 medical products, including diagnostic tests and clinical management supplies, in low- and middle-income countries.UNICEF